Doença de Chagas, ambiente, participação e Estado

Dias, João Carlos Pinto

doi:10.1590/s0102-311x2001000700026

Cited by 42 publications

(17 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This fi nding is in agreement with others reports in the literature, which indicated that CD carriers generally belong to low socioeconomic and cultural classes that have been excluded by poverty and disease, having little power to make demands and virtually no political visibility (12) .…”

supporting

confidence: 93%

Trypanosoma cruzi seroprevalence and associated risk factors in cancer patients from Southern Brazil

Rosenthal

Petrarca

Mesenburg

et al. 2016

Rev. Soc. Bras. Med. Trop.

View full text Add to dashboard Cite

Introduction:The aim of this study was to investigate the prevalence of Chagas disease in patients treated at a Public Oncology Service in the City of Pelotas, Southern Brazil. Methods: This study included 200 individuals undergoing cancer treatment and involved the use of a questionnaire and venous blood collection for the detection of anti-Trypanosoma cruzi antibody. Results: The study found a 5% prevalence of patient seropositivity. Signifi cant variables are presented and discussed in the article. Conclusions: Serological T. cruzi checks are recommended in cancer patients, especially individuals from endemic areas in Brazil and other Latin American countries.

show abstract

supporting

confidence: 93%

Trypanosoma cruzi seroprevalence and associated risk factors in cancer patients from Southern Brazil

Rosenthal

Petrarca

Mesenburg

et al. 2016

Rev. Soc. Bras. Med. Trop.

View full text Add to dashboard Cite

show abstract

“…É fato que no Brasil existe uma escassez de recursos públicos destinados à saúde, é calculado que o governo aplique cerca de 200 dólares por pessoa/ano para a saúde, cifra bastante reduzida frente às reais necessidades e aos montantes disponíveis em países mais desenvolvidos 35 . Segundo Dias 36 , ao lado da falta de cultura e de experiência para ações como a vigilância epidemiológica na doença de Chagas em níveis mais periféricos, os problemas mais evidentes têm natureza político-administrativa, dependendo muito pouco de técnicos, cientistas e inovações tecnológicas.…”

Section: Discussão E Conclusõesunclassified

Vigilância epidemiológica da doença de Chagas em programa descentralizado: avaliação de conhecimentos e práticas de agentes municipais em região endêmica de Minas Gerais, Brasil

Villela

Souza²,

Melo³

et al. 2007

Cad. Saúde Pública

Self Cite

View full text Add to dashboard Cite

O objetivo deste trabalho foi avaliar a vigilância epidemiológica sobre a doença de Chagas na região centro-oeste de Minas Gerais, Brasil, a partir dos conhecimentos e práticas adotadas pelos agentes municipais que trabalham no Programa de Controle da Doença de Chagas. Com esse propósito, foram realizadas viagens para 35 municípios da região, nas quais foram feitas reuniões e aplicação de questionário sobre os conhecimentos, práticas e dificuldades que os agentes municipais apresentam na realização do trabalho. A maioria dos agentes (26) apresenta contrato anual, e apenas dois são efetivos pela prefeitura. Setenta e sete vírgula um por cento dos agentes falaram que a população apresenta problemas para identificar triatomíneos. Vinte e três funcionários relataram serem boas as condições que o município oferece para realização do programa, mas 27 fizeram sugestões, solicitando especialmente mais material educativo, melhores salários e maior valorização do cargo pela prefeitura. Algumas providências são apontadas em relação ao momento atual do programa, pois a etapa de vigilância é crucial para a consolidação dos resultados alcançados.

show abstract

“…We hypothethize that the rarity of the diagnosis of CD's disease currently, the occurrence of CCC provided between the patients, and the controversy regarding the therapeutic use of BZN for the treatment of these patients may have contributed to the low use of the drug among patients selected in this study [6]. In addition, BZN treatment offered to patients with CD was more prominent in the past decades [29]. CD is considered a typical tropical neglected disease and receives less attention from the media.…”

Section: Discussionmentioning

confidence: 99%

Benznidazole Use among Patients with Chronic Chagas' Cardiomyopathy in an Endemic Region of Brazil

et al. 2016

View full text Add to dashboard Cite

Chagas disease (CD) is a neglected tropical disease that affects individuals in almost every country in Latin America. There are two available drugs with antiparasitic profiles; however, only benznidazole (BZN) has been approved for commercialization in Brazil. The usefulness of prescribing BZN for patients with chronic Chagas cardiomyopathy (CCC) is controversial. There are no studies in the literature describing the extent of BZN use at this stage or the profile of patients using this drug. The present study aimed to determine the prevalence and factors associated with previous BZN use among individuals with CCC. This cross-sectional study was conducted with 1,812 individuals with CCC from 21 Brazilian cities endemic for CD. The dependent variable was "prior use of BZN" (no vs. yes). The independent variables were grouped into socioeconomic, lifestyle and medical history aspects. Binary logistic regression (α ≥ 0.05) was used. Among the evaluated individuals, 27.2% reported previous use of BZN. The likelihood of prior use of BZN was higher among younger individuals (OR = 2.7), individuals with a higher education (OR = 2.7), individuals with a lower monthly per capita income (OR = 1.3), individuals who practiced physical exercise (OR = 1.5), individuals who had prior knowledge of the CD diagnosis (OR = 2.5), individuals without hypertension (OR = 1.3) and individuals with a longer time to the CD diagnosis (OR = 6.1). The present study revealed a small proportion of therapeutic BZN use among Brazilian CCC patients. This finding suggests a late diagnosis and undertreatment of the disease. BZN use was higher among individuals with better clinical and demographic conditions but with a lower income and a longer time to the CD diagnosis. Knowledge of the BZN usage profile may help reduce the current state of neglect of this disease and pave the way for future studies.

show abstract

Doença de Chagas, ambiente, participação e Estado

Abstract: Human Chagas Disease (HCD) affects 16 million Latin Americans and is related to environmental and social questions like education, anthropogenic changes, housing, and migration. HCD requires domiciliation of the vector, which is introduced

Cited by 42 publications

References 6 publications

Trypanosoma cruzi seroprevalence and associated risk factors in cancer patients from Southern Brazil

Trypanosoma cruzi seroprevalence and associated risk factors in cancer patients from Southern Brazil

Vigilância epidemiológica da doença de Chagas em programa descentralizado: avaliação de conhecimentos e práticas de agentes municipais em região endêmica de Minas Gerais, Brasil

Benznidazole Use among Patients with Chronic Chagas' Cardiomyopathy in an Endemic Region of Brazil

Contact Info

Product

Resources

About